PLGA Market Size 2024 – Current Sales Analysis, Upcoming Trends, Opportunities, Development History, and Future Forecast

PLGA Market Size 2024 - Current Sales Analysis, Upcoming Trends, Opportunities, Development History, and Future Forecast

“Browse 152 market data Tables and 52 Figures spread through 200 Pages and in-depth TOC on “PLGA Market”
PLGA demand is growing due to its biocompatibility and biodegradability, especially in drug delivery and tissue engineering. Rising healthcare investments and a shift toward sustainable materials further support its market expansion.

The PLGA market is projected to reach USD 321 million by 2030, at a CAGR of 16.6% from USD 125 million in 2024. The market growth is driven by influencing factors such as government initiatives and regulations and exceptional biodegradability and biocompatibility nature. The PLGA market is driven by several factors, including technological advancements, shifting consumer behaviors, favorable economic conditions, expanding applications in various industries, and growing demand. The increasing use of PLGA in various end-use industries, such as healthcare, biotech firms, medical institutions, packaging, textile, and agriculture, is a significant driver for market growth.

PLGA Market Keyplayers

The key global players in the PLGA market include Evonik (Germany), Corbion NV (Netherlands), Ashland (US), Mitsui Chemicals (Japan), Jinan Digang Bioengineering Co., Ltd. (China), Merck (Germany), Akina, Inc. (US), Nomisma Healthcare Pvt. Ltd. (India), Bezwada Biomedical, LLC (US), CD Bioparticles (US) are the key players in the PLGA market. These companies are strong in their home region and explore geographic diversification alternatives to grow their businesses. They focus on increasing their market shares through new product launches and other expansions.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=143024577

Evonik

Evonik is one of the global leading specialty chemical companies. The company operates under 6 divisions: Specialty additives, Nutrition & Care, Smart Materials, Performance Materials, Technology & Infrastructure, Enabling Functions, and Others. It offers polylactic co-glycolic acid (PLGA) under the specialty nutrition & care segment. The company manufactures PLGA under the brand names “Lactel” and “Resomer”. These brands have strong records for safety and timely delivery of complex parenteral drug products. The biodegradable polymers offered by Evonik are available with either acid or esters end groups. The company serves its products to various end-use industries such as paint & coatings, agriculture, construction, plastics, rubber, pharmaceuticals, paper & printing, electrical & electronics, consumer & personal care products, and many others. The company has a global presence, operates in more than 100 countries, and 84% of sales are generated outside Germany. The production capacities are in Germany, Belgium, the USA, China, and Singapore.

Corbion NV

Corbion is a global leader in providing sustainable ingredient solutions. The company operates under 4 business segments, namely, sustainable food solutions, lactic acid & specialties, algae ingredients, and non-core activities. The company’s product line includes antioxidants, biochemical products, biomedical products, chemical products, pharma products, bioplastic products, and many others. The company provides PLGA under the brand “PURASORB”. Corbion offers high-quality PLGA polymers for precise dosages over extended periods, manufactured in advanced facilities and recognized as safe by regulatory agencies such as the FDA.

Get Sample Copy of this Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=143024577

The company markets its products through a worldwide network of sales offices and distributors and has a global supply chain with manufacturing facilities in the US, Thailand, Brazil, Mexico, the Netherlands, and Spain.

“Packaging is the fastest growing end-use industry of the PLGA, in terms of value.”

Packaging stands as a pivotal end-use industry for PLGA (poly (lactic-co-glycolic acid), offering a promising avenue for sustainable and innovative solutions in the global packaging market. PLGA, renowned for its biodegradability, biocompatibility, and versatility, finds applications across various packaging sectors. In recent years, the packaging industry has witnessed a paradigm shift towards eco-friendly materials, driven by consumer demand for sustainable packaging solutions and tightening regulations governing plastic waste. PLGA emerges as a compelling alternative to traditional petroleum-based plastics, offering properties conducive to packaging applications such as films, coatings, and containers. Its ability to degrade into harmless byproducts under controlled conditions aligns with the circular economy principles, addressing concerns related to environmental pollution and resource depletion.

Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=143024577

“North America captures the largest share in the PLGA market during the forecast period, in terms of value.”

The PLGA market in North America stands as a vibrant and evolving landscape within the realm of biodegradable polymers. Fueled by factors such as increasing demand for advanced drug delivery systems, growing investments in biomedical research, and stringent regulatory requirements promoting biocompatible materials, the market exhibits significant growth potential. North America, with its robust pharmaceutical and healthcare industries, serves as a key hub for PLGA adoption and innovation. Pharmaceutical companies are increasingly integrating PLGA into their product pipelines to develop controlled-release formulations for a wide array of therapeutics, including small molecules, biologics, and nucleic acid-based drugs. Moreover, advancements in PLGA manufacturing technologies and the emergence of novel applications beyond drug delivery, such as tissue engineering scaffolds and medical implants, further propel market expansion.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry. 

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/plga-market-143024577.html